Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study.
Beiling LiYanhang GaoXianbo WangZhiping QianZhongji MengYan HuangGuohong DengXiaobo LuFeng LiuXin ZhengHai LiJinjun ChenPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Bacterascites patients had non-negligible poor clinical outcomes, including in-hospital AKI, progression to ACLF and 28-day mortality. Future studies are warranted to expedite the diagnosis of bacterascites and optimize antibiotic treatment.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- healthcare
- prognostic factors
- risk factors
- cardiovascular disease
- acute kidney injury
- type diabetes
- patient reported outcomes
- emergency department
- current status
- drug induced
- smoking cessation
- adverse drug
- case control